Improving heart and metabolic health in people with severe mental illness
Official title: Longitudinal Approach to Generate Positive Cardiometabolic Health Outcomes in Severe Mental Illness
Run by Vastra Gotaland Region · NCT06781801 · Data updated 2026-11-12
This study is testing a new program to help people with severe mental illness, like schizophrenia, improve their heart and overall health by promoting healthier lifestyles.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 650 (estimated) |
| Sponsor | Vastra Gotaland Region Government |
| Locations | 6 sites (Gothenburg and 5 other locations) |
| Status | Recruiting |
| Started | February 27, 2025 |
| Main results expected | December 31, 2029 |
| Study ends | December 31, 2029 |
| Registry record updated | August 11, 2026 |
| Trial ID | NCT06781801 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older diagnosed with schizophrenia spectrum disorders.
✕Probably not a fit
Patients with electrical medical implants, pregnant women, or those deemed unsuitable by the investigator may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial focuses on enhancing cardiometabolic health in individuals with psychotic disorders, who often face significant health challenges. The study will involve 644 adults diagnosed with schizophrenia spectrum disorders, recruited from six outpatient clinics in Gothenburg. Participants will receive a comprehensive intervention program designed to promote healthy lifestyles and improve quality of life. The approach leverages the regular visits to outpatient clinics and the expertise of diverse health professionals to deliver individualized care.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the cardiometabolic health and overall quality of life for individuals with severe mental illness.
How similar studies have gone: While there is ongoing research in this area, this specific comprehensive intervention approach is novel and has not been extensively tested in similar populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria 1. Adults ≥18 years of age meeting the International Classification of Diseases, Tenth Revision (ICD-10) diagnostic criteria for any one of the schizophrenia spectrum disorders (F20-F25 or F28-F29) 2. Ability to provide informed consent Exclusion criteria 1. Having an electrical medical implant such as a pacemaker or other mechanical implants 2. Pregnancy 3. Deemed unsuitable by the investigator: A person may be deemed unsuitable for participation if circumstances prevent safe or reliable participation in the trial. Examples include inability or unwillingness to maintain contact with the clinic (e.g., absence of a stable address or telephone number), planned relocation or transfer to another treatment facility, municipality, or country during the trial period, mobility limitations or other practical barriers preventing attendance at clinic visits, or administrative restrictions preventing appropriate documentation in medical records or trial databases (e.g., protected or anonymous identity status). Such decisions are made on an individual basis in consultation with the clinical team (case manager (CM), treating psychiatrist, and site principal investigator (PI)) to ensure patient safety and trial integrity. 4. Prior participation in the LAGOM trial during a previous inclusion cycle (i.e., participants can only be included once during the trial period). 5. Currently under compulsory care.
Where it's running
-
Psykosmottagning Centrum
Gothenburg, Sweden Recruiting -
Psykosmottagning Nordost
Gothenburg, Sweden Recruiting -
Psykosmottagning Öster
Gothenburg, Sweden Recruiting -
Psykosmottagning Hisingen
Gothenburg, Sweden Recruiting -
Psykosmottagning Väster
Gothenburg, Sweden Recruiting -
Psykosmottagning Mölndal
Mölndal, Sweden Recruiting
Study contacts
- Study coordinator: Hemen Najar, M.D., Ph.D.
- Email: hemen.najar@vgregion.se
- Phone: 0046 73 566 15 64
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Theta-Burst Transcranial Magnetic Stimulation for Treatment-Resistant Auditory Hallucinations
This study tests whether theta-burst transcranial magnetic stimulation can lessen persistent auditory verbal hallucinations in adults with schizophrenia-spectrum or psychotic disorders who have not responded to antipsychotic meds.
-
Small Soteria-inspired unit vs. standard closed ward for acute psychosis
A randomized or semi-randomized comparison tests whether a small Soteria-style inpatient unit improves outcomes for adults with acute psychosis compared to a conventional closed psychiatric ward.
-
Accelerated Brain Stimulation for Young People at Risk of Psychosis
This study tests a five-day accelerated brain-stimulation treatment to see if it is safe and tolerable for young people at risk for psychosis and to explore biomarkers that might show whether it works.
-
Racial differences in how people experience paranoia
This project will see if brief race-related stressful experiences increase feelings of paranoia in Black American adults who take online surveys.
-
Yoga-based group program plus usual care for outpatients with schizophrenia spectrum disorders
This project will see if a 12-week yoga-based group program added to usual outpatient care helps adults with schizophrenia spectrum disorders reduce stress and symptom-related distress compared with exercise or usual care alone.
-
Trying the Kiso Mind smartphone app for people with schizophrenia spectrum disorders
This study tests whether the Kiso Mind smartphone app is acceptable, practical, and helpful for adults with schizophrenia or schizoaffective disorder alongside their usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.